THE EFFECT OF CARBIDOPA ON THE PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED LEVODOPA - THE MECHANISM OF ACTION IN THE TREATMENT OF PARKINSONISM

被引:142
作者
NUTT, JG
WOODWARD, WR
ANDERSON, JL
机构
[1] OREGON HLTH SCI UNIV,DEPT PHARMACOL,PORTLAND,OR 97201
[2] OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201
[3] OREGON HLTH SCI UNIV,PHARM SERV,PORTLAND,OR 97201
关键词
D O I
10.1002/ana.410180505
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:537 / 543
页数:7
相关论文
共 24 条
[1]   EFFECT OF VARIOUS DECARBOXYLASE INHIBITORS ON CEREBRAL METABOLISM OF DIHYDROXYPHENYLALANINE [J].
BARTHOLINI, G ;
PLETSCHER, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (05) :323-+
[2]   BLOOD-BRAIN BARRIER TO CARBIDOPA (MK-486) AND RO4-4602, PERIPHERAL DOPA DECARBOXYLASE INHIBITORS [J].
CLARK, WG ;
OLDENDORF, WH ;
DEWHURST, WG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :416-418
[3]   INFLUENCE OF ROUTE OF ADMINISTRATION ON PHYSIOLOGICAL AVAILABILITY OF LEVODOPA IN DOGS [J].
COTLER, S ;
HOLAZO, A ;
BOXENBAUM, HG ;
KAPLAN, SA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (06) :822-827
[4]   KINETICS OF ABSORPTION AND EXCRETION OF LEVODOPA IN DOGS [J].
COUTINHO, CB ;
SPIEGEL, HE ;
KAPLAN, SA ;
YU, M ;
CHRISTIAN, RP ;
CARBONE, JJ ;
SYMINGTON, J ;
CHERIPKO, JA ;
LEWIS, M ;
TONCHEN, A ;
CREWS, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (07) :1014-+
[5]  
DAVIS VE, 1960, J BIOL CHEM, V235, P124
[6]  
DOLLER HJ, 1978, DRUG METAB DISPOS, V6, P164
[7]  
DUNNER DL, 1971, CLIN PHARMACOL THER, V12, P212
[8]   ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM - CLINICAL AND PHARMACOLOGIC CORRELATIONS AND EFFECT OF INTRAMUSCULAR PYRIDOXINE [J].
FAHN, S .
NEUROLOGY, 1974, 24 (05) :431-441
[9]   BLOOD-BRAIN-BARRIER TRANSPORT AND CEREBRAL UTILIZATION OF DOPA IN LIVING MONKEYS [J].
GARNETT, ES ;
FIRNAU, G ;
NAHMIAS, C ;
SOOD, S ;
BELBECK, L .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 238 (05) :R318-R327
[10]  
Gibaldi M., 1984, BIOPHARMACEUTICS CLI, P17